Tag Archives: FDA

FDA Issues New PDF Specifications

  In the chaos of the holidays, you might have missed the release of an important new guidance from FDA.  On 20 December 2011, FDA issued version 3 of “FDA Portable Document Format (PDF) Specifications,” fulfilling a promise made at … Continue reading

Posted in eCTD, FDA | Tagged , , , | 1 Comment

Fifth China Medicinal Biotech Forum – Conference Recap

I recently returned from the Fifth China Medicinal Biotech Forum held in Beijing, China from 07-09 November 2011.  The purpose of this conference was to update graduate students in China on the latest trends in biotechnology.  This forum also allowed … Continue reading

Posted in Clinical Trials, Conferences and Meetings | Tagged , , , , , , , , , , , , , , , , , | Comments Off

Free Webinar – Optimal Clinical Study Designs and International Regulatory Strategies

Please join us at a joint webinar between the Netherlands Centre for Human Drug Development (CHDR) and Cato Research that addresses current challenges and provides clinical and regulatory strategies to the most expeditious and cost-effective path towards clinical proof of concept and approval. The webinar will be held on Tuesday, 15 November 2011 from 1:00 to 2:00 PM ET. Continue reading

Posted in Clinical Trials, Regulatory Strategy, Webinars | Tagged , , , , , , , , , , , , | Comments Off

Project Management for Biotech Companies

In today’s fast paced, high pressure world of drug development there are multiple factors that can and do affect marketing success.  Large organizations understand the value that project management can contribute to a successful project.  The smaller companies tend to … Continue reading

Posted in Clinical Trials, Project Management, Regulatory Strategy | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Pre-IND Submissions in eCTD Format

Historically, we made our Pre-IND submissions in paper (e.g., Pre-IND meeting request, briefing package, and meeting minutes) and we began using eCTD format with the initial IND submission.  However, since FDA assigns a Pre-IND number, which ultimately becomes the IND … Continue reading

Posted in eCTD, FDA, Regulatory Strategy | Tagged , , , , | Comments Off